SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Martin Michaelis Alexander F. Yakunin Lars Kaderali Jindrich Cinatl Philipp Ströbel Hanna-Mari Baldauf Federico Comoglio Veit Hornung Hubert Serve |
| Publication date | December 19, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |